As compared to conventional, stand-alone clinical trials in advanced non-small cell lung cancer (NSCLC), the biomarker-driven Lung Cancer Master Protocol (Lung-MAP) has enrolled higher percentages of patients who are older, patients who are from rural or socioeconomically deprived areas, and patients who have Medicaid or no insurance.
National Comprehensive Cancer Network awards grants for small cell lung cancer research healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
Pedro Barata, MD, MSc, discusses important considerations regarding the relationship between immunotherapy treatment and the gut microbiome when treating patients with kidney cancer.
Dr. Denlinger is currently NCCNs Chief Scientific Officer and previously served as Chair and Member of multiple NCCN Guidelines Panels in charge of maintaining gold-standard evidence-based expert consensus cancer treatment recommendations.Today the